Questcor Pharmaceuticals makes appointments
This article was originally published in Scrip
Questcor Pharmaceuticals (US) has appointed Dr David Young, currently a member of the company's board of directors, to the newly created position of chief scientific officer, and has appointed Dr Sian Bigora to the newly created position of vice-president of regulatory affairs. Dr Young joins Questcor from AGI Therapeutics, where he had served as executive director and president of US operations since 2006. Dr Bigora also joins from AGI Therapeutics, where she was vice-president of clinical research and regulatory affairs. Both executives will be based at the company's new east coast offices in Columbia, Maryland.